Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. Rising Prevalence of IBS-C, OIC, and Chronic Constipation
4.1.1.2. Increasing Geriatric Population
4.1.1.3. Development of Latest Drugs and Treatment Procedures
4.1.2. Restraints:
4.1.2.1. Increasing Dependence on Majority of Over-the-Counter (OTC) Drugs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Pipeline Analysis
5.4. Supply Chain Analysis
5.5. Pricing Analysis
5.6. Product Innovations
5.7. Unmet Needs
5.8. Comparative Scenario
6. By Disease Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type Segment
6.1.2. Market Attractiveness Index, By Disease Type Segment
6.2. Opioid-induced constipation (OIC)
6.2.1.1. Introduction
6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Chronic idiopathic constipation (CIC)
6.4. Irritable bowel syndrome with constipation (IBS-C)
7. By Therapeutic
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Segment
7.1.2. Market Attractiveness Index, By Therapeutic Segment
7.2. Chloride channel activators
7.2.1.1. Introduction
7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Laxatives
7.3.1. Bulk-forming agents
7.3.2. Osmotic laxatives
7.3.3. Stimulant laxatives
7.3.4. Others
7.4. GC-C Agonists
7.5. Peripherally Acting Mu-Opioid Receptor Antagonists
7.6. 5-HT4 Receptor Agonists
8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
8.1.2. Market Attractiveness Index, By Distribution Channel Segment
8.2. Hospital Pharmacies
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Retail Pharmacies
8.4. Online Pharmacies
9. By Country
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. Brazil
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3. Argentina
9.4. Colombia
9.5. Peru
9.6. Rest of South America
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Disease Type Disease Types Benchmarking
10.4. List of Key Companies to Watch
11. Company Profiles
11.1. Takeda Pharmaceutical Company Ltd
11.1.1. Company Overview
11.1.2. Disease Type Disease Type Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Abbott Laboratories
11.3. Daewoong Pharmaceuticals
11.4. AstraZeneca
11.5. Sanofi
11.6. Bausch Health Companies Inc.
11.7. Bayer AG
11.8. Janssen Pharmaceutical
LIST NOT EXHAUSTIVE
12. South America Constipation Market – DataM
12.1. Appendix
12.2. About Us and Distribution Channel
12.3. Contact Us